Vanguard Asset Management’s Sionna Therapeutics SION Stock Holding History
Bought
Maintained
Sold
Other funds holding SION
Vanguard Asset Management's SION Position: Q3 2026 in Review
Vanguard Asset Management held its Sionna Therapeutics (SION) position steady in Q3 2026 at 9,535 shares worth $50.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2416.
Vanguard Asset Management first reported a position in SION in Q2 2026 and has held it in 2 quarters since. The position peaked at $419K in Q2 2026. 136 funds tracked by Wall St. Rank hold SION as of Q3 2026.
- Vanguard Asset Management held 9,535 shares of Sionna Therapeutics worth $50.2K as of Q3 2026.
- Vanguard Asset Management left its Sionna Therapeutics share count unchanged in Q3 2026.
- Sionna Therapeutics made up ﹤0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #2416 holding.
- Vanguard Asset Management first reported a position in Sionna Therapeutics in Q2 2026 and has held it in 2 quarters since.
- Vanguard Asset Management's Sionna Therapeutics position peaked at $419K in Q2 2026.
- 136 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q3 2026.
Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.